These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4625992)

  • 1. A clinical evaluation of glibenclamide (HB 419, "Daonil") a new antidiabetic sulphonylurea.
    Cheah JS
    Singapore Med J; 1972 Apr; 13(2):87-90. PubMed ID: 4625992
    [No Abstract]   [Full Text] [Related]  

  • 2. The clinical evaluation of an oral antidiabetic drug.
    Müller R
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glibenclamide, a new oral antidiabetic].
    Edlén A
    Lakartidningen; 1972 Jan; 69(4):342-3. PubMed ID: 4622487
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E; Garcia RV; Barberia Layana JJ; Morant Ciscard JA; Calleja Canelas A
    Curr Ther Res Clin Exp; 1977 Jan; 21(1):50-7. PubMed ID: 401712
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical testing of a sulphonylurea derivative, glibornuride].
    Zöllner N; Dörfler H; Wolfram G
    Dtsch Med Wochenschr; 1972 Jul; 97(29):1083-8. PubMed ID: 4625427
    [No Abstract]   [Full Text] [Related]  

  • 6. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
    Emanueli A; Molari E; Pirola LC; Caputo G
    Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
    [No Abstract]   [Full Text] [Related]  

  • 7. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
    J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with a new hypoglycemic agent, glibenclamide, HB 419 (Daonil) in diabetes mellitus.
    Ser I
    Isr J Med Sci; 1972 Jun; 8(6):887. PubMed ID: 4626318
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
    Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N
    Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of a new oral drug in the treatment of diabetes mellitus].
    Lubetzki J
    Diabete; 1971; 19(3):185-90. PubMed ID: 5002990
    [No Abstract]   [Full Text] [Related]  

  • 13. [New aspects of therapy with oral antidiabetic agents].
    Haslbeck M
    Wien Med Wochenschr; 1979 Dec; 199(24):689-95. PubMed ID: 161940
    [No Abstract]   [Full Text] [Related]  

  • 14. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical comparison between glibornuride (Glutril) and tolbutamide in maturity-onset diabetes: a controlled double-blind trial.
    Lindbjerg IF; Christoffersen EM; Kuusisto A; Lodahl K; Sagild U; Sterling N; Mikkelsen BO
    Curr Ther Res Clin Exp; 1976 Sep; 20(3):277-82. PubMed ID: 134878
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
    Vernet A; Fabre J; Zahnd G
    Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical testing of a sulfonylurea preparation (glibenclamide)].
    Sigroth K; Steen B; Svanborg A
    Lakartidningen; 1969 Nov; 66(45):4647-50. PubMed ID: 4996889
    [No Abstract]   [Full Text] [Related]  

  • 18. [Incidence and severity of treatment-induced hypoglycemias in diabetics].
    Hasslacher C; Wahl P
    Dtsch Med Wochenschr; 1971 Nov; 96(46):1787-91. PubMed ID: 5000535
    [No Abstract]   [Full Text] [Related]  

  • 19. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled extension of oral antidiabetic therapy on former insulin dependent diabetics by means of the combined i.v. glibenclamide-glucose-response-test.
    Pfeiffer EF; Raptis S
    Diabetologia; 1972 Feb; 8(1):41-7. PubMed ID: 4623790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.